监测韦切利地方卫生机构的抗生素使用情况,以此作为应对急性呼吸道感染的一项措施。

Igiene e sanita pubblica Pub Date : 2023-11-01
Rossana Monciino, Antonella Barbieri, Maddalena Galante, Roberta Giacometti, Alice Mastrogiacomo, Luca Rabbiosi
{"title":"监测韦切利地方卫生机构的抗生素使用情况,以此作为应对急性呼吸道感染的一项措施。","authors":"Rossana Monciino, Antonella Barbieri, Maddalena Galante, Roberta Giacometti, Alice Mastrogiacomo, Luca Rabbiosi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In 2022 the Italian Ministry of Health published the National Antibiotic Resistance Plan (PNCAR) 2022 - 2025 which provides the strategic guidelines and operational indications for dealing with the emergency of antimicrobial resistance (AMR). ESAC recorded, in the year 2021, an average consumption of 16.4 DDD/1000 inhab. res. die, with a statistically significant decrease in the period 2012 -2021 for class J01, on total territorial and hospital consumption. Italy is one of the countries with the highest consumption of antibiotics, it ranks 9th with a total hospital and territorial consumption of 17.53 DDD/1000 inhab. res. die. The present study aims to monitor the territorial consumption of antibiotics in ASL VC through the analysis of synthetic indicators and ESAC indicators, comparing them with regional and national values. Through the IQVIA database, a retrospective descriptive study was conducted on the consumption of antibiotics (ATC J01), for the period 2020 - 2022, measuring the synthetic indicators of consumption (DDD1,000 inhab. res. die) and costs (value1,000 inhab. res. die). Subsequently, a second analysis was carried out by measuring the ESAC indicators for the year 2022, comparing them with the previous year or period. With regard to consumption, while a reduction (average -7%) was observed for contracted pharmaceuticals (CONV) in 2021 compared to 2020, followed by an increase in 2022 (average +31%); for private purchase (PRIV), consumption remained constant in 2021 and then increased in 2022 (average +40%). The same trend was observed for the costs of the J01 class. The ESAC indicators show a mild improvement for ASL VC (variable for regional and national level), except for the use of 3rd and 4th generation cephalosporins which recorded an increase in 2022. The reduction in the consumption of antibiotics in 2021, followed by an increase in 2022 can be partly explained by the pandemic period that has just ended which led to the return to the community with the resumption of infectious agents in circulation. It therefore becomes essential to pay particular attention to antibiotic stewardship activities, both in the hospital and on the territory. (community).</p>","PeriodicalId":73329,"journal":{"name":"Igiene e sanita pubblica","volume":"80 6","pages":"118-127"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Monitoring of the territorial consumption of antibiotics in local health authority of Vercelli as a measure to contrast AMR.\",\"authors\":\"Rossana Monciino, Antonella Barbieri, Maddalena Galante, Roberta Giacometti, Alice Mastrogiacomo, Luca Rabbiosi\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In 2022 the Italian Ministry of Health published the National Antibiotic Resistance Plan (PNCAR) 2022 - 2025 which provides the strategic guidelines and operational indications for dealing with the emergency of antimicrobial resistance (AMR). ESAC recorded, in the year 2021, an average consumption of 16.4 DDD/1000 inhab. res. die, with a statistically significant decrease in the period 2012 -2021 for class J01, on total territorial and hospital consumption. Italy is one of the countries with the highest consumption of antibiotics, it ranks 9th with a total hospital and territorial consumption of 17.53 DDD/1000 inhab. res. die. The present study aims to monitor the territorial consumption of antibiotics in ASL VC through the analysis of synthetic indicators and ESAC indicators, comparing them with regional and national values. Through the IQVIA database, a retrospective descriptive study was conducted on the consumption of antibiotics (ATC J01), for the period 2020 - 2022, measuring the synthetic indicators of consumption (DDD1,000 inhab. res. die) and costs (value1,000 inhab. res. die). Subsequently, a second analysis was carried out by measuring the ESAC indicators for the year 2022, comparing them with the previous year or period. With regard to consumption, while a reduction (average -7%) was observed for contracted pharmaceuticals (CONV) in 2021 compared to 2020, followed by an increase in 2022 (average +31%); for private purchase (PRIV), consumption remained constant in 2021 and then increased in 2022 (average +40%). The same trend was observed for the costs of the J01 class. The ESAC indicators show a mild improvement for ASL VC (variable for regional and national level), except for the use of 3rd and 4th generation cephalosporins which recorded an increase in 2022. The reduction in the consumption of antibiotics in 2021, followed by an increase in 2022 can be partly explained by the pandemic period that has just ended which led to the return to the community with the resumption of infectious agents in circulation. It therefore becomes essential to pay particular attention to antibiotic stewardship activities, both in the hospital and on the territory. (community).</p>\",\"PeriodicalId\":73329,\"journal\":{\"name\":\"Igiene e sanita pubblica\",\"volume\":\"80 6\",\"pages\":\"118-127\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Igiene e sanita pubblica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Igiene e sanita pubblica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

2022 年,意大利卫生部发布了《2022-2025 年国家抗生素耐药性计划》(PNCAR),为应对抗生素耐药性(AMR)紧急情况提供了战略方针和操作指南。根据 ESAC 的记录,到 2021 年,全国和医院的抗生素总消费量为 16.4 DDD/1000,其中 J01 类抗生素的消费量在 2012 - 2021 年期间出现了统计意义上的显著下降。意大利是抗生素消耗量最高的国家之一,医院和地区的总消耗量为 17.53 DDD/1,000名居民,排名第9位。本研究旨在通过分析合成指标和 ESAC 指标,将其与地区和国家数值进行比较,从而监测 ASL VC 地区的抗生素消耗量。通过 IQVIA 数据库,对 2020 - 2022 年期间抗生素(ATC J01)的消耗量进行了回顾性描述研究,测量了消耗量(DDD1,000 居民死亡)和成本(价值1,000 居民死亡)的合成指标。随后,通过测量 2022 年的 ESAC 指标,将其与上一年或上一时期进行比较,进行了第二次分析。在消费方面,与 2020 年相比,2021 年合同药品(CONV)的消费量减少(平均-7%),但 2022 年又有所增加(平均+31%);在私人购买药品(PRIV)方面,2021 年的消费量保持不变,但 2022 年又有所增加(平均+40%)。J01 级的费用也呈现出同样的趋势。ESAC 指标显示,除了第三代和第四代头孢菌素的使用量在 2022 年有所增长外,ASL VC 的使用量略有改善(地区和国家层面均有不同)。2021 年抗生素用量减少,2022 年用量增加的部分原因是大流行期刚刚结束,导致传染病菌重新回到社区流通。因此,无论是在医院还是在社区,都必须特别关注抗生素管理活动。(社区)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Monitoring of the territorial consumption of antibiotics in local health authority of Vercelli as a measure to contrast AMR.

In 2022 the Italian Ministry of Health published the National Antibiotic Resistance Plan (PNCAR) 2022 - 2025 which provides the strategic guidelines and operational indications for dealing with the emergency of antimicrobial resistance (AMR). ESAC recorded, in the year 2021, an average consumption of 16.4 DDD/1000 inhab. res. die, with a statistically significant decrease in the period 2012 -2021 for class J01, on total territorial and hospital consumption. Italy is one of the countries with the highest consumption of antibiotics, it ranks 9th with a total hospital and territorial consumption of 17.53 DDD/1000 inhab. res. die. The present study aims to monitor the territorial consumption of antibiotics in ASL VC through the analysis of synthetic indicators and ESAC indicators, comparing them with regional and national values. Through the IQVIA database, a retrospective descriptive study was conducted on the consumption of antibiotics (ATC J01), for the period 2020 - 2022, measuring the synthetic indicators of consumption (DDD1,000 inhab. res. die) and costs (value1,000 inhab. res. die). Subsequently, a second analysis was carried out by measuring the ESAC indicators for the year 2022, comparing them with the previous year or period. With regard to consumption, while a reduction (average -7%) was observed for contracted pharmaceuticals (CONV) in 2021 compared to 2020, followed by an increase in 2022 (average +31%); for private purchase (PRIV), consumption remained constant in 2021 and then increased in 2022 (average +40%). The same trend was observed for the costs of the J01 class. The ESAC indicators show a mild improvement for ASL VC (variable for regional and national level), except for the use of 3rd and 4th generation cephalosporins which recorded an increase in 2022. The reduction in the consumption of antibiotics in 2021, followed by an increase in 2022 can be partly explained by the pandemic period that has just ended which led to the return to the community with the resumption of infectious agents in circulation. It therefore becomes essential to pay particular attention to antibiotic stewardship activities, both in the hospital and on the territory. (community).

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信